Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending T
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
analysts
Biotech
In first, autoimmune patients respond to allogeneic CAR-T cells
The study is the first sign of the potential of allogeneic CAR-T therapies in treating autoimmune diseases, according to William Blair analysts.
Darren Incorvaia
Jul 17, 2024 3:26pm
Sanofi tries to quiet naysayers with data on Principia MS drug
Oct 14, 2021 10:05am
Pfizer stumbles close to finish line in growth hormone race
Sep 27, 2021 7:05am
Pfizer deal a spark for M&A, or fuel for an empty pipeline?
Aug 24, 2021 9:32am
AbbVie's oral migraine treatment atogepant nears FDA decision
Aug 20, 2021 10:20am
UPDATE: Roche stays focused on phase 3 data for Alzheimer's drug
Jul 1, 2021 8:00am
